A review of the chemotherapeutic management of colorectal cancer is presented.doi:10.1046/j.1365-2036.2003.01735.xS GillR R ThomasR M GoldbergAlimentary Pharmacology & TherapeuticsGill S, Thomas RR, Goldberg RM: Review article: colorectal cancer chemotherapy. Aliment Pharmacol Ther 2003, 18:683-...
Review article: a molecular rationale for the how, when and why of colorectal cancer screening doi:10.1046/j.1365-2036.2001.00935.xUNITED StatesCOLON cancer diagnosisMEDICAL screeningPOLYPSColorectal cancer remains a leading cause of cancer‐related mortality in the...
A review of the current state of the art of colorectal cancer screening. Article CAS PubMed Google Scholar Warthin, A. S. Heredity with reference to carcinoma: as shown by the study of the cases examined in the pathological laboratory of the University of Michigan. Arch. Intern. Med. 12...
Colorectal cancer is the third most common type of cancer diagnosed in the United States and is the third most common cause of cancer-related death. The majority of cases are sporadic, with hereditary colon cancer contributing up to 15% of all colon cancer diagnoses. Treatment consists of surge...
Article PubMed Google Scholar REACCT Collaborative Characteristics of early-onset vs late-onset colorectal cancer: a review. JAMA Surg. 156, 865–874 (2021). Article Google Scholar Bailey, C. E. et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the...
In this article, we review the current evidence for the use of these and other agents for the chemoprevention of colorectal cancer, together with theories as to their possible mechanisms of action. 展开 DOI: http://dx.doi.org/ 被引量: 79 ...
Here, we review our current understanding of how colon cancer cells interact with their microenvironment, comprised of immune cells, stromal cells and the intestinal microbiome, to suppress or escape immune responses and how inflammatory processes shape the immune pathogenesis of CRC....
摘要: Advances in immunology and molecular biology have shown that colorectal cancer is potentially immunogenic and that host immune responses influence survival. However, immune surveillance and activation is frequently ineffective in preventing and/or controlling tumour growth....
Download Review Bookmark Cite as... There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience. Abstract Colorectal cancer (CRC) ranks as the third most prevalent malignancy and second...
Colorectal cancer remains a challenging heterogeneous disease with substantial morbidity and mortality. However, progressive advances over the past year have led to marked improvements and overcome challenges previously considered insurmountable. Here, we review key clinical trials in colorectal cancer in 2024...